Evidence map›Paper›PMID 35239150›Full record

ArticleUpdates in surgery2022

Feasibility and usability of a regional hub model for colorectal cancer services during the COVID-19 pandemic.

Filipe Carvalho, Ailín C Rogers, Tou-Pin Chang, Yinshan Chee, Dhivya Subramaniam, Gianluca Pellino, Katy Hardy, Christos Kontovounisios, Paris Tekkis, Shahnawaz Rasheed and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Updates in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. The 'hub' model for colorectal surgery: a viable paradigm shift?Annals of the Royal College of Surgeons of England · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Filipe CarvalhoDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Ailín C RogersDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Tou-Pin ChangDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Yinshan CheeDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Dhivya SubramaniamDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Gianluca PellinoDepartment of Advanced Medical and Surgical Sciences, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.ORCID http://orcid.org/0000-0002-8322-6421
Katy HardyDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Christos KontovounisiosDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK. c.kontovounisios@imperial.ac.uk.
Paris TekkisDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
Shahnawaz RasheedDepartment of Colorectal Surgery, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK.
London Colorectal Cancer Hub Network Collaborators
Chelsea and Westminster Hospital NHS Foundation Trust · GBRoyal Marsden NHS Foundation Trust · GBUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the COVID-19 pandemic produced unprecedented challenges, at a global level, in the provision of cancer care. With the ongoing need in the delivery of life-saving cancer treatment, the surgical management of patients with colorectal cancer required prompt significant transformation. The aim of this retrospective study is to report the outcome of a bespoke regional Cancer Hub model in the delivery of elective and essential colorectal cancer surgery, at the height of the first wave of the COVID-19 pandemic. 168 patients underwent colorectal cancer surgery from April 1st to June 30th of 2020. Approximately 75% of patients operated upon underwent colonic resection, of which 47% were left-sided, 34% right-sided and 12% beyond total mesorectal excision surgeries. Around 79% of all resectional surgeries were performed via laparotomy, and the remainder 21%, robotically or laparoscopically. Thirty-day complication rate, for Clavien-Dindo IIIA and above, was 4.2%, and 30-day mortality rate was 0.6%. Re-admission rate, within 30 days post-discharge, was 1.8%, however, no patient developed COVID-19 specific complications post-operatively and up to 28 days post-discharge. The established Cancer Hub offered elective surgical care for patients with colorectal cancer in a centralised, timely and efficient manner, with acceptable post-operative outcomes and no increased risk of contracting COVID-19 during their inpatient stay. We offer a practical model of care that can be used when elective surgery "hubs" for streamlined delivery of elective care needs to be established in an expeditious fashion, either due to the COVID-19 pandemic or any other future pandemics.

Indexed as

COVID-19Rectal NeoplasmsAftercareFeasibility StudiesHumansPandemicsPatient DischargeRetrospective StudiesSARS-CoV-2CancerColorectal surgeryCOVID-19SARS-CoV-2

Identifiers

PMID35239150
PMCPMC8891734
OpenAlexW4214834665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.